Related Experiment Video
Updated: Sep 28, 2026

Purification of Hepatocytes and Sinusoidal Endothelial Cells from Mouse Liver Perfusion
Published on: February 12, 2018
Review of methods to remove protein-bound substances in liver failure
1Institute of Liver Studies, Guy's, King's & St Thomas' School of Medicine, King's College, London, UK. robin.hughes@kcl.ac.uk
Abstract:
A wide range of toxic substances accumulates in the circulation of patients with liver failure, including more lipid-soluble substances, which bind to plasma proteins. Serum albumin is the most important binding protein for ligands such as bilirubin and bile acids, which are potentially toxic and can cause apoptosis in astrocytes and hepatocytes respectively in vitro. Resin haemoperfusion was originally investigated to remove these compounds, as well as inflammatory cytokines. Current effective methods for removal of protein-bound compounds in patients with liver failure include high volume plasmapheresis and different forms of albumin dialysis. Bioartificial liver support systems need adsorbent and/or dialysis modules to replace the lack of excretory function.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Drug Distribution: Plasma Protein Binding
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

